Clinical Trials on Erythrocyte Transfusion

Total 413 results

Leiden University Medical Center
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA); Sanquin...

Recruiting

PRedicting OutcomeS in Preterm nEonates With thromboCyTopenia (PROSPECT) (PROSPECT)

Intraventricular Hemorrhage | Neonatal Thrombocytopenia | Platelet Transfusion

Netherlands, Sweden
Editas Medicine, Inc.

Recruiting

EDIT-301 for Autologous Hematopoietic Stem Cell Transplant (HSCT) in Participants With Transfusion-Dependent Beta Thalassemia (TDT)

Hemoglobinopathies | Thalassemia Major | Thalassemia Intermedia | Transfusion Dependent Beta Thalassemia

United States, Canada
Konkuk University Medical Center
Samsung Medical Center; Asan Medical Center; Korea Health Industry Development... and other collaborators

Recruiting

Goal-directed vs. Empirical Tranexamic Acid Administrationin Cardiovascular Surgery

Heart Diseases | Vascular Diseases | Fibrinolysis; Hemorrhage | Transfusion Related Complication | Coagulation Disorder, Blood

Korea, Republic of
Nantes University Hospital
Ministry of Health, France

Completed

Cost-Utility Analysis of Management of Peri Operative Haemorrhage Following Cardiac Surgery With Cardiopulmonary Bypass (IMOTEC)

Blood Coagulation Disorders | Blood Transfusion | C.Surgical Procedure; Cardiac | Bypass, Cardiopulmonary | Hemostatic

France
International Centre for Diarrhoeal Disease Research...
University of British Columbia; Muhimbili University of Health and Allied Sciences

Recruiting

Management of Shock in Children With SAM or Severe Underweight and Diarrhea

Shock, Septic | Blood Transfusion | Dopamine | Adrenaline | Shock Hypovolemic

Bangladesh
Universidad Autonoma de Nuevo Leon

Completed

Oral Tranexamic Acid vs. Oral Aminocaproic Acid to Reduce Blood Loss and Transfusion After Total Knee Replacement.

Knee Osteoarthritis | Blood Loss | Blood Clot | Transfusion Related Complication

Mexico
Editas Medicine, Inc.

Not yet recruiting

A Long-Term Follow-Up Study of Participants With Sickle Cell Disease or Transfusion Dependent β-Thalassemia Who Received EDIT-301

Sickle Cell Disease | Hemoglobinopathies | Transfusion-dependent Beta-Thalassemia
Institute of Hematology & Blood Diseases Hospital

Recruiting

Growth and Development-related Outcomes in Children With Transfusion-dependent Beta-thalassemia After Gene Therapy

Gene Therapy | Transfusion-dependent Beta-Thalassemia

China
Tampere University Hospital

Withdrawn

ROTEM-guided Transfusion Protocol in Attempt to Reduce Blood Transfusions in Major Oncological Surgery (ROTEM-SUR)

Blood Loss, Surgical | Coagulation Defect; Acquired | Blood Loss Requiring Transfusion

Finland
Novartis Pharmaceuticals

Withdrawn

Deferasirox BID (Twice a Day) in Transfusion Dependent Thalassemia Patients With Inadequate Response to High Doses

Focus on Transfusion Dependent Thalassemia Patients Who Are Inadequate Responders to Deferasirox > 35mg/kgQD
Novartis Pharmaceuticals

Completed

Efficacy and Safety of Deferasirox in Non-transfusion Dependent Thalassemia Patients With Iron Overload and a One Year Open-label Extension Study (THALASSA)

Non-transfusion Dependent Thalassemia

Greece, Taiwan, Italy, United Kingdom, Lebanon, Turkey, Malaysia, Thailand, United States
Hormozgan University of Medical Sciences

Completed

Efficacy and Safety of Desferal Versus Osveral in Transfusional Iron Overload

Iron Overload | Thalassemia | Transfusion Related Complications

Iran, Islamic Republic of
Centre Hospitalier Universitaire de Nice

Completed

Continous Renal Replacement Therapy With the CARPEDIEM® in a French National Cohort of 25 Neonates and Small Infants

Kidney Diseases | Sepsis | Pulmonary Disease | Hypoxic-Ischemic Encephalopathy | Cardiac Disease | Metabolic Disease | Twin to Twin Transfusion Syndrome

France
University of Campania "Luigi Vanvitelli"

Completed

Endocrine Function During Deferasirox Therapy

Iron Overload | Endocrine; Complications | Transfusion-dependent Thalassemia

Italy
Diskapi Teaching and Research Hospital
Turkish Society of Anesthesiology and Reanimation

Completed

Investigation of the Transfusion Practices in Surgical Patients in Turkey (CeKATU)

Anemia | Surgery | Coagulation Disorder | Blood Loss, Surgical | Blood Transfusion | Blood Loss Anemia

Turkey
Sunnybrook Health Sciences Centre
Princess Margaret Hospital, Canada; Juravinski Cancer Center

Unknown

Red Blood Cell Transfusion Thresholds and QOL in MDS (EnhanceRBC)

Quality of Life | Myelodysplastic Syndromes (MDS) | Red Blood Cell (RBC) Transfusions

Canada
Novartis Pharmaceuticals

Completed

Efficacy and Safety of Deferasirox in Patients With Myelodysplastic Syndrome and Transfusion-dependent Iron Overload

Myelodysplastic Syndromes | Transfusion Dependent Iron Overload

Germany
Children's Hospital of Chongqing Medical University

Recruiting

Hepatitis B Vaccination After Neonatal Surgery

Hepatitis B Virus Infection | Hepatitis B Vaccine Adverse Reaction | Blood Transfusion Complication | Vaccination Reaction | Digestive System Disorders of Fetus and Newborn

China
University Hospital, Montpellier

Completed

SvO2 Trigger in Transfusion Strategy After Cardiac Surgery (ReTSEACS)

Undergoing Nonemergent Cardiac Surgery | Central Venous Catheter on the Superior Vena Cava (to Perform ScVO2 Measure) | Anemia (<9g/dL) Requiring Blood Transfusion | Hemodynamic and Respiratory Stability | Bleeding Graded as Insignificant, Mild, Moderate of Universal Definition of Perioperative...

France
Regeneron Pharmaceuticals

Not yet recruiting

A Study to Test the Safety, Tolerability, and Efficacy of an Antibody, REGN7999, Injected Under the Skin for the Treatment of Iron Overload in Adult Participants With Non-Transfusion Dependent β-thalassemia, Using MRI Scans to Measure Iron Levels in the Body (FERVENT-1)

Non-transfusion Dependent Beta-thalassemia (NTDT)
Hospital Universitari de Bellvitge

Completed

Implementation of a Patient Blood Management Program in Gastric Cancer Surgery (IPAT)

Gastric Cancer | Surgery--Complications | Anemia, Iron Deficiency | Transfusion Related Complication
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Transfusion Safety Study (TSS)

HIV Infections | Acquired Immunodeficiency Syndrome | Blood Transfusion
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Effectiveness of AIDS Antibody Screening

HIV Infections | Acquired Immunodeficiency Syndrome | Blood Transfusion
Novartis Pharmaceuticals

Completed

A Protocol to Allow Treatment With ICL670 for Patients With or at Risk of Life-threatening Complications of Transfusional Iron Overload Who Are Unable to Tolerate Other Iron Chelators Because of Documented Severe Toxicity

Transfusional Iron Overload

United States, Greece, Italy
Novartis Pharmaceuticals

Completed

Observation of Patients With Transfusional Hemosiderosis Treatment With Deferasirox

Transfusional Hemosiderosis

Egypt, Spain, United Kingdom, Jordan
National Heart, Lung, and Blood Institute (NHLBI)

Completed

HIV Diversity and Pathogenesis in Donor-Recipient Clusters

HIV Infections | Acquired Immunodeficiency Syndrome | Blood Transfusion | Blood Donors
Novartis Pharmaceuticals

Terminated

Safety and Efficacy of Deferasirox in Combination With Desferoxamine in β-thalassaemia Patients With Severe Cardiac Iron Overload

Cardiac Iron Overload | Transfusion-dependent β-thalassemia Patients

Greece
Angel Augusto Perez Calatayud
Grupo Mexicano para el Estudio de la Medicina Intensiva

Completed

Patient Blood Management for Massive Obstetric Hemorrhage

Post Partum Hemorrhage | Transfusion Related Complication | Fibrinogenolysis; Hemorrhage | Fibrinogen; Deficiency, Acquired | Massive Hemorrhage

Mexico
University Health Network, Toronto

Completed

MR Imaging of Diffuse Myocardial Fibrosis in Transfusion-Dependent Anemias (MAFIO)

Thalassemia Major | Chronic Blood Transfusion Related Iron Overload

Canada
Instituto de Investigación Hospital Universitario...

Completed

Complications Associated With Intraoperative Hypothermia.

Hypothermia | Hemorrhage, Postpartum | Transfusion-dependent Anemia | Infection Surgical Wound

Spain
Juan Blanco Morillo
Instituto Murciano de Investigación Biosanitaria Virgen de la Arrixaca

Completed

Haemo-autologous Antegrade Repriming (HAR) as Minimum Impact Perfusion Strategy for Cardiopulmonary Bypass (HARjbm1)

Embolism, Air | Anemia | Cardiac Disease | Valve Anomalies | Extracorporeal Circulation; Complications | Transfusion | Cognitive; Disorder, Due to General Medical Condition

Spain
Silence Therapeutics plc

Withdrawn

Study in Beta-thalassaemia or Myelodysplastic Syndrome Patients to Investigate the Safety and Tolerability of SLN124

Non-transfusion-dependent Thalassemia | Low Risk Myelodysplastic Syndrome

United Kingdom, Bulgaria
University of California, San Francisco

Terminated

Pilot Trial of Clofarabine Added to Standard Busulfan and Fludarabine for Conditioning Prior to Allogeneic Hematopoietic Cell Transplantation

Myeloid Malignancy | Metabolic Disease | Bone Marrow Failure Syndrome | Transfusion-dependent Red Blood Cell (RBC) Defect | Congenital Immunodeficiency | Severe Immune Dysregulation

United States
Novartis Pharmaceuticals

Completed

Palatability and Tolerability of Deferasirox Taken With Meals, With Different Liquids or Crushed and Added to Food

Transfusional Hemosiderosis

United States
Children's Hospital Los Angeles
Novartis Pharmaceuticals

Terminated

Clinical Importance of Treating Iron Overload in Sickle Cell Disease

Anemia, Sickle Cell | Transfusion Hemosiderosis

United States
Novartis Pharmaceuticals

Terminated

Myelodysplastic Syndrome (MDS) Gastrointestinal (GI) Tolerability Study (MACS1574)

Myelodysplastic Syndrome | Transfusional Iron Overload

Spain, France, Italy, South Africa
Novartis Pharmaceuticals

Completed

Efficacy and Safety of Deferasirox in Patients With Chronic Anemia and Transfusional Hemosiderosis

Transfusional Hemosiderosis | Chronic Anemia

Japan, Turkey, Spain, Poland, Singapore
Sheba Medical Center
Hadassah Medical Organization; Kaplan Medical Center; Tel Aviv Medical Center; Ziv...

Completed

Effect of Deferiprone on Oxidative-Stress and Iron-Overload in Low Risk Transfusion-Dependent MDS Patients

Myelodysplastic Syndrome With Low-grade Lesions | Iron Overload Due to Repeated Red Blood Cell Transfusions

Israel
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Viral Activation Transfusion Study (VATS)

HIV Infections | Acquired Immunodeficiency Syndrome | Cytomegalovirus Infections | Blood Transfusion
Boston Children's Hospital
Novartis

Completed

Pilot Study for Patients With Poor Response to Deferasirox

Sickle Cell Disease | Thalassemia Major | Transfusion-dependent Hemachromatosis

United States
Silence Therapeutics plc

Completed

A Study Investigate the Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Response of SLN124 in Adults With Alpha/Beta-thalassaemia and Very Low- and Low-risk Myelodysplastic Syndrome

Non-transfusion-dependent Thalassemia | Low Risk Myelodysplastic Syndrome | Very-Low Risk Myelodysplastic Syndrome

Thailand, Israel, Jordan, United Kingdom, Germany, Italy, Malaysia
St Vincent's Hospital, Sydney

Completed

Blood Management During ECMO for Cardiac Support (OBLEX)

Hemorrhage | Embolism | Venous Thrombosis | Arrhythmias, Cardiac | Shock, Cardiogenic | Blood Transfusion | Death, Sudden, Cardiac | Disseminated Intravascular Coagulation | HEART ARREST

Australia
Xiaoping Fan. MD
Jie He.MD; Shihao Cai.MD; Wenda Gu.PhD; Haijiang Guo.PhD; Liang Hong. MD; Ruixing Fan... and other collaborators

Unknown

A Comparative Study of Different Hypothermic Circulatory Arrest Strategies on Aortic Surgery.

Aneurysm | Blood Transfusion | Dialysis | Neurological Disorder | Morality | Endoleak | Operation Time | Hospital Stay | Hypothermic Circulatory Arrest Time | Aortic-cross Clamping Time | Cardiopulmonary Bypass Time | Re-Thoracotomy | ICU Stay | Mechanical Ventilation Time

China
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Retrovirus Epidemiology Donor Study I (REDS I)

HIV Infections | Acquired Immunodeficiency Syndrome | Retroviridae Infections | Blood Transfusion | HIV-1 | Blood Donors | HIV-2 | HTLV-I | HTLV-II
Medical College of Wisconsin
National Heart, Lung, and Blood Institute (NHLBI); University of Wisconsin,... and other collaborators

Recruiting

Fetal Electrophysiologic Abnormalities in High-Risk Pregnancies Associated With Fetal Demise

Sudden Infant Death | Congenital Heart Disease | Pregnancy Loss | Gastroschisis | Fetal Death | Brugada Syndrome | High Risk Pregnancy | Stillbirth | Long QT Syndrome | Fetal Demise | Birth Defect | Twin Monochorionic Monoamniotic Placenta | Twin Twin Transfusion Syndrome | Fetal Hydrops | Fetal Arrhythmia | Intrauterine... and other conditions

United States
Shire

Terminated

Safety, Efficacy and Pharmacokinetics of an Oral Iron Chelator Given for a Year to Pediatric Patients With Iron Overload

Beta-Thalassemia | Transfusional Iron Overload

United States, Lebanon, Canada, Italy, Turkey
Novartis Pharmaceuticals

Completed

Phase I Study to Examine the Effect of Deferasirox on Renal Hemodynamics in β-thalassemia Patients With Transfusional Iron Overload

Transfusional Iron Overload | β-thalassemia

Italy
Shire

Completed

Safety and Pharmacodynamic Study of an Oral Iron Chelator Given for 6 Months to Patients With Iron Overload

Beta-thalassemia | Transfusional Iron Overload

United States, United Kingdom, Italy, Thailand, Turkey
FerroKin BioSciences, Inc.

Completed

Safety and Pharmacokinetic Study of Escalating Multiple Doses of an Iron Chelator in Patients With Iron Overload

Beta-thalassemia | Transfusional Iron Overload

United States, Australia, Thailand
Novartis Pharmaceuticals

Completed

An Extension Study of Iron Chelation Therapy With Deferasirox (ICL670) in β-thalassemia Patients With Transfusional Iron Overload

Transfusional Iron Overload in β-thalassemia

United States, Greece, Argentina, Germany, Belgium, Italy, United Kingdom, France, Tunisia, Canada, Turkey, Brazil

Clinical Trials on Erythrocyte Transfusion

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Saint Lucia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations